Meropenem-vaborbactam: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "== Background == === Mechanism of Activity === * Vaborbactam is active against KPC carbapenemases == Safety == === Monitoring === * Seizures, thrombocytopenia, drug inter..." |
No edit summary |
||
| Line 4: | Line 4: | ||
* Vaborbactam is active against KPC carbapenemases |
* Vaborbactam is active against KPC carbapenemases |
||
== Dosing == |
|||
* Carbapenem-resistant infection with [[Enterobacterales]]: 4 g IV every 8 hours |
|||
* Complicated [[urinary tract infection]]: 4 g IV every 8 hours for 5 to 14 days |
|||
== Safety == |
== Safety == |
||
Revision as of 16:07, 27 June 2025
Background
Mechanism of Activity
- Vaborbactam is active against KPC carbapenemases
Dosing
- Carbapenem-resistant infection with Enterobacterales: 4 g IV every 8 hours
- Complicated urinary tract infection: 4 g IV every 8 hours for 5 to 14 days
Safety
Monitoring
- Seizures, thrombocytopenia, drug interaction with valproic acid
